Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Peter Campbell – The Wellcome Trust Sanger Inst

Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Speaker: Karin Vanderkerken, PhD (she/her/hers) – Vrije Universiteit Brusssels

Speaker: Madhav V. Dhodapkar, MD, MBBS (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA

Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Speaker: Anthony Cirrincione, PhD – Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami

Speaker: Wen Zhou, PhD – Cancer Research Institute, Xiangya School of Medicine, Central South University

Speaker: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre

Speaker: Leif Bergsagel, MD – Mayo Clinic Arizona

Panelist: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA

Panelist: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University

Panelist: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre

Panelist: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona

Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca

Co-Chair: S. Vincent Rajkumar, MD – Mayo Clinic

Speaker: Saad Z. Usmani, MD MBA FACP – Memorial Sloan Kettering Cancer Center

Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France

Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK

Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Speaker: Thomas Lund, MD, PhD (he/him/his) – Department of Hematology Odense University Hospital

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Speaker: Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Speaker: S. Vincent Rajkumar, MD – Mayo Clinic

Panelist: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center

Panelist: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France

Panelist: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE

Panelist: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil

Panelist: Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy

Panelist: Bindu Kanapuru

Speaker: S. Vincent Rajkumar, MD – Mayo Clinic

Speaker: Siddhartha Mukherjee

Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Paolo Ghia, MD. PhD (he/him/his) – Università Vita-Salute San Raffaele

Speaker: Jacqueline Cloos, PhD (she/her/hers) – Amsterdam UMC, location VUMC, Cancer Center Amsterdam

Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration

Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center

Speaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Speaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University

Speaker: Felipe Prosper, MD (he/him/his) – Clinica Universidad de Navarra

Speaker: Arun P. Wiita, MD, PhD – University of California San Francisco, San Francisco, CA, USA

Speaker: Maximilian Merz, MD (he/him/his) – University of Leipzig

Speaker: Laura Lucia Cogrossi – San Raffaele Scientific Institute

Speaker: Andrea Poletti, PhD – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy

Speaker: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center

Panelist: Sonja Zweegman, MD, PhD – Amsterdam UMC

Panelist: Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole

Panelist: Wilson I. Gonsalves, MD – Mayo Clinic, Rochester

Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France

Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Speaker: Lawrence Boise, PhD (he/him/his) – Emory University

Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Speaker: Shuntaro Ikegawa, MD, PhD – Dana-Farber Cancer Institute

Speaker: Alexandra M. Poos, PhD (she/her/hers) – Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg

Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany

Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Panelist: P. Joy Ho, MBBS DPhil FRACP FRCPA (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital

Panelist: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Panelist: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens

Panelist: Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre

Panelist: Ajai Chari, MD, PhD – University of California, San Francisco

Panelist: Bindu Kanapuru

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute

Speaker: Flavia Pichiorri, PhD (she/her/hers) – City of Hope

Speaker: Marc-A. Baertsch, MD – German Cancer Research Center (DKFZ)

Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Co-Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center

Speaker: Adam D Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC

Speaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA

Speaker: Joshua Richter, MD – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Speaker: Hui Liu, LH – Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, China

Speaker: Luis-Esteban Tamariz-Amador, MD – Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA

Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC

Speaker: Noopur Raje, MD – Massachusetts General Hospital Cancer Center

Panelist: Jesus G. Berdeja, MD – Sarah Cannon Research Institute

Panelist: Ivan Borrello, MD – Tampa General Hospital

Panelist: Tom Martin, MD (he/him/his) – UCSF

Panelist: Monika Engelhardt

Panelist: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center

Co-Chair: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens

Co-Chair: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens

Speaker: Steven Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana Farber Cancer Institute

Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine

Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Co-Chair: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital

Speaker: Moritz Binder, MD MPH (he/him/his) – Mayo Clinic

Speaker: Laura Rosinol, MD, PhD (she/her/hers) – Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain

Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France

Speaker: Ioannis V Kostopoulos, n/a – Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece

Speaker: Clark DuMontier, MD, MPH (he/him/his) – VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School

Speaker: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada

Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS – National University Cancer Institute, Singapore

Panelist: Sundar Jagannath, MD, FASCO – Mount Sinai Medical Center, New York, NY, USA

Panelist: Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada

Panelist: Cristina Gasparetto, MD (she/her/hers) – Department of Medicine, Duke University Cancer Institute, Durham, NC

Panelist: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France